Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation
- PMID: 18054563
- DOI: 10.1053/j.gastro.2007.08.041
Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation
Abstract
Background & aims: Butyrate oxidation is impaired in intestinal mucosa of patients with inflammatory bowel diseases (IBD). Butyrate uptake by colonocytes involves the monocarboxylate transporter (MCT) 1. We aimed to investigate the role of MCT1 in butyrate oxidation deficiency during colonic inflammation.
Methods: Colonic tissues were collected from patients with IBD or healthy controls and from rats with dextran sulfate sodium (DSS)-induced colitis. The intestinal epithelial cell line HT-29 was treated with interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha). MCT1 expression was analyzed by real-time reverse-transcription polymerase chain reaction, Western blot, and immunofluorescence. Butyrate uptake and oxidation in HT-29 cells was assessed using [(14)C]-butyrate. The mechanism of MCT1 gene regulation was analyzed by nuclear run-on and reporter gene assays.
Results: MCT1 messenger RNA (mRNA) and protein levels were markedly decreased in inflamed colonic mucosa of IBD patients and rats. In HT-29 cells, down-regulation of MCT1 mRNA and protein abundance by IFN-gamma and TNF-alpha correlated with a decrease in butyrate uptake and subsequent oxidation. IFN-gamma and TNF-alpha did not affect MCT1 mRNA stability but rather down-regulated gene transcription. We demonstrate that the cytokine response element is located in the proximal -111/+213 core region of the MCT1 promoter.
Conclusions: The data suggest that butyrate oxidation deficiency in intestinal inflammation is a consequence of reduction in MCT1-mediated butyrate uptake. This reinforces the proposition that butyrate oxidation deficiency in IBD is not a primary defect.
Similar articles
-
Regulation of monocarboxylate transporter 1 (MCT1) promoter by butyrate in human intestinal epithelial cells: involvement of NF-kappaB pathway.J Cell Biochem. 2008 Apr 1;103(5):1452-63. doi: 10.1002/jcb.21532. J Cell Biochem. 2008. PMID: 17786924 Free PMC article.
-
Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1.J Physiol. 2002 Mar 1;539(Pt 2):361-71. doi: 10.1113/jphysiol.2001.014241. J Physiol. 2002. PMID: 11882670 Free PMC article.
-
Monocarboxylate 4 mediated butyrate transport in a rat intestinal epithelial cell line.Dig Dis Sci. 2013 Mar;58(3):660-7. doi: 10.1007/s10620-012-2407-x. Epub 2013 Jan 24. Dig Dis Sci. 2013. PMID: 23344966
-
Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency.Inflamm Bowel Dis. 2010 Apr;16(4):684-95. doi: 10.1002/ibd.21108. Inflamm Bowel Dis. 2010. PMID: 19774643 Review.
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
Cited by
-
Postbiotics, Metabolic Signaling, and Cancer.Molecules. 2021 Mar 11;26(6):1528. doi: 10.3390/molecules26061528. Molecules. 2021. PMID: 33799580 Free PMC article. Review.
-
Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy.Clin Transl Sci. 2018 Jul;11(4):352-364. doi: 10.1111/cts.12551. Epub 2018 Apr 16. Clin Transl Sci. 2018. PMID: 29660777 Free PMC article. Review.
-
The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective.Front Immunol. 2023 Oct 9;14:1277102. doi: 10.3389/fimmu.2023.1277102. eCollection 2023. Front Immunol. 2023. PMID: 37876938 Free PMC article. Review.
-
MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation.Nat Commun. 2024 Jan 2;15(1):163. doi: 10.1038/s41467-023-44540-0. Nat Commun. 2024. PMID: 38167945 Free PMC article.
-
Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery.PLoS One. 2012;7(3):e32841. doi: 10.1371/journal.pone.0032841. Epub 2012 Mar 6. PLoS One. 2012. Retraction in: PLoS One. 2019 Oct 30;14(10):e0224849. doi: 10.1371/journal.pone.0224849. PMID: 22412931 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources